HMGB1 as a key mediator in liver disease pathogenesis
Liver diseases, both acute and chronic, continue to pose significant clinical challenges due to high morbidity and mortality rates. Acute ...
Tag: Fatty Liver
Liver function discovery could revolutionize treatments for cardiovascular disease
A new discovery about how the liver flushes cholesterol from the body could lead to more effective treatments for cardiovascular ...
New research explores hydrogen sulfide as treatment for obesity
Therapies that deliver hydrogen sulfide to cells could one day become the basis of new treatments for obesity and related ...
Inflammation may not be key to fighting liver fibrosis in MAFLD
Researchers at UCLA Health uncovered new information about the role inflammation plays in mitigating liver fibrosis, which is associated with ...
SH2B1 gene defends against obesity via the paraventricular hypothalamus
Obesity is a complicated condition, caused by a combination of genetics, the food environment, behavior, and other factors. For millennia, ...
Specific class of drugs can reverse diet-induced obesity, fatty liver and diabetes in mice
Researchers at Karolinska Institutet may have found a new way to treat obesity and related disorders by targeting the cells' ...
Study aims to explore the underlying causes of excessive alcohol production in overweight people
The microorganisms in the intestines of many overweight people produce alcohol to an increased extent, as Max Nieuwdorp, professor of ...
Risk of non-alcoholic fatty liver disease for cardiovascular disease and all cause death in patients with type 2 diabetes mellitus
In a recent study published in the British Medical Journal, researchers investigated the link between non-alcoholic fatty liver disease (NAFLD) ...
Patients with non-alcoholic fatty liver disease may benefit from increased dietary niacin intake
In a recent large-scale prospective cohort study published in JAMA Network Open, researchers evaluated whether higher dietary niacin intake lowers the risk ...
Noninvasive diagnostic tool for identification of NASH by visualizing hepatic steatosis and inflammation
Non-alcoholic fatty liver disease (NAFLD), recently renamed metabolic dysfunction-associated fatty liver disease (MAFLD), is spectrum of diseases that ranges from ...
